7. ShangPharma (SHP) is a leading Chinese contract research organization (CRO) for the pharmaceutical and biotechnology industry. The company offers a broad range of integrated services for the discovery and development of drug candidates. ShangPharma will release its 2010 fourth quarter results on Mar. 15.
China Earnings: 10 Stocks With Upside
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.